1 - [6 - (morpholin-4-yl) pyrimidin-4-yl] - 4 - (1H - 1,2,3 - triazol 1 - il) - 1H pyrazole - 5 - olato Sodium, Preparation Method, Pharmaceutical Composition and use in the Treatment or prophylaxis of diseases such as heart failure, anemia, renal failure and ENF. Cardiovascular.
The present application relates to sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate, to processes for its preparation, to its use for the treatment and/or prophylaxis of diseases and to its use for the preparation of medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and haematological diseases and kidney diseases, and for promoting wound healing.<；p>；LA PRESENTE SOLICITUD SE REFIERE A <；em>；1 <；/em>；-[6-(MORFOLIN-4-IL)PIRIMIDIN-4-IL]-4-(1 H-1 ,2,3-TRIAZOL-1 - iI1)-I1-1-PIRAZOL-5-O1ATO SÁ；DICO, Y A SU PROCEDIMIENTO DE PREPARACIÓ；N QUE COMPRENDE HACER REACCIONAR EL COMPUESTO DE FÓ；RMULA (1) EN UN DISOLVENTE CON HIDRÓ；XIDO DE SODIO O SODA CÁ；USTICA ACUOSA O UNA SAL SÁ；DICA, EN SU CASO CON LA ADICIÓ；N DE TRIETILAMINA O DIISOPROPILETILAMINA.<；/p>；
